Overexpression of miR-196b and HOXA10 characterize a poor-prognosis gastric cancer subtype

Jae Yun Lim, SunOch Yoon, So Young Seol, Soon Won Hong, Jong Won Kim, Seung Ho Choi, Ju Seog Lee, Jae Yong Cho

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

AIM: To identify molecular biologic differences between two gastric adenocarcinoma subgroups presenting different prognoses through the analysis of microRNA and protein expression. METHODS: Array technologies were used to generate 1146 microRNAs and 124 proteins expression profiles of samples from 60 patients with gastric cancer. For the integrative analysis, we used established mRNA expression data published in our previous study. Whole mRNA expression levels were acquired from microarray data for 60 identical gastric cancer patients. Two gastric adenocarcinoma subgroups with distinct mRNA expression profiles presented distinctly different prognoses. MicroRNA and protein expression patterns were compared between gastric cancer tissue and normal gastric tissue and between two different prognostic groups. Aberrantly expressed microRNA, associated mRNA, and protein in patients with poor-prognosis gastric cancer were validated by quantitative reverse transcription polymerase chain reaction and immunochemistry in independent patients. RESULTS: We obtained the expression data of 1146 microRNAs and 124 cancer-related proteins. Four microRNAs were aberrantly expressed in the two prognostic groups and in cancer vs non-cancer tissues (P < 0.05). In the poor-prognosis group, miR-196b, miR- 135b, and miR-93 were up-regulated and miR-29c* was down-regulated. miR-196b expression positively correlated with Homeobox A10 (HOXA10) expression (r = 0.726, P < 0.001), which was significantly increased in poor-prognosis patients (P < 0.001). Comparing gastric cancer with non-cancer tissues, 46/124 proteins showed differential expression (P < 0.05); COX2 (P < 0.001) and cyclin B1 (P = 0.017) were clearly overexpressed in the poor-prognosis group. CONCLUSION: Co-activation of miR-196b and HOXA10 characterized a poor-prognosis subgroup of patients with gastric cancer. Elucidation of the biologic function of miR-196b and HOXA10 is warranted.

Original languageEnglish
Pages (from-to)7078-7088
Number of pages11
JournalWorld Journal of Gastroenterology
Volume19
Issue number41
DOIs
Publication statusPublished - 2013 Nov 7

Fingerprint

Homeobox Genes
antineoplaston A10
Stomach Neoplasms
MicroRNAs
Stomach
Messenger RNA
Proteins
Adenocarcinoma
Cyclin B1
Immunochemistry
Reverse Transcription
Neoplasms
Technology
Polymerase Chain Reaction

All Science Journal Classification (ASJC) codes

  • Gastroenterology

Cite this

Lim, Jae Yun ; Yoon, SunOch ; Seol, So Young ; Hong, Soon Won ; Kim, Jong Won ; Choi, Seung Ho ; Lee, Ju Seog ; Cho, Jae Yong. / Overexpression of miR-196b and HOXA10 characterize a poor-prognosis gastric cancer subtype. In: World Journal of Gastroenterology. 2013 ; Vol. 19, No. 41. pp. 7078-7088.
@article{c2a1241dc2134c45adc216340d736a95,
title = "Overexpression of miR-196b and HOXA10 characterize a poor-prognosis gastric cancer subtype",
abstract = "AIM: To identify molecular biologic differences between two gastric adenocarcinoma subgroups presenting different prognoses through the analysis of microRNA and protein expression. METHODS: Array technologies were used to generate 1146 microRNAs and 124 proteins expression profiles of samples from 60 patients with gastric cancer. For the integrative analysis, we used established mRNA expression data published in our previous study. Whole mRNA expression levels were acquired from microarray data for 60 identical gastric cancer patients. Two gastric adenocarcinoma subgroups with distinct mRNA expression profiles presented distinctly different prognoses. MicroRNA and protein expression patterns were compared between gastric cancer tissue and normal gastric tissue and between two different prognostic groups. Aberrantly expressed microRNA, associated mRNA, and protein in patients with poor-prognosis gastric cancer were validated by quantitative reverse transcription polymerase chain reaction and immunochemistry in independent patients. RESULTS: We obtained the expression data of 1146 microRNAs and 124 cancer-related proteins. Four microRNAs were aberrantly expressed in the two prognostic groups and in cancer vs non-cancer tissues (P < 0.05). In the poor-prognosis group, miR-196b, miR- 135b, and miR-93 were up-regulated and miR-29c* was down-regulated. miR-196b expression positively correlated with Homeobox A10 (HOXA10) expression (r = 0.726, P < 0.001), which was significantly increased in poor-prognosis patients (P < 0.001). Comparing gastric cancer with non-cancer tissues, 46/124 proteins showed differential expression (P < 0.05); COX2 (P < 0.001) and cyclin B1 (P = 0.017) were clearly overexpressed in the poor-prognosis group. CONCLUSION: Co-activation of miR-196b and HOXA10 characterized a poor-prognosis subgroup of patients with gastric cancer. Elucidation of the biologic function of miR-196b and HOXA10 is warranted.",
author = "Lim, {Jae Yun} and SunOch Yoon and Seol, {So Young} and Hong, {Soon Won} and Kim, {Jong Won} and Choi, {Seung Ho} and Lee, {Ju Seog} and Cho, {Jae Yong}",
year = "2013",
month = "11",
day = "7",
doi = "10.3748/wjg.v19.i41.7078",
language = "English",
volume = "19",
pages = "7078--7088",
journal = "World Journal of Gastroenterology",
issn = "1007-9327",
publisher = "WJG Press",
number = "41",

}

Overexpression of miR-196b and HOXA10 characterize a poor-prognosis gastric cancer subtype. / Lim, Jae Yun; Yoon, SunOch; Seol, So Young; Hong, Soon Won; Kim, Jong Won; Choi, Seung Ho; Lee, Ju Seog; Cho, Jae Yong.

In: World Journal of Gastroenterology, Vol. 19, No. 41, 07.11.2013, p. 7078-7088.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Overexpression of miR-196b and HOXA10 characterize a poor-prognosis gastric cancer subtype

AU - Lim, Jae Yun

AU - Yoon, SunOch

AU - Seol, So Young

AU - Hong, Soon Won

AU - Kim, Jong Won

AU - Choi, Seung Ho

AU - Lee, Ju Seog

AU - Cho, Jae Yong

PY - 2013/11/7

Y1 - 2013/11/7

N2 - AIM: To identify molecular biologic differences between two gastric adenocarcinoma subgroups presenting different prognoses through the analysis of microRNA and protein expression. METHODS: Array technologies were used to generate 1146 microRNAs and 124 proteins expression profiles of samples from 60 patients with gastric cancer. For the integrative analysis, we used established mRNA expression data published in our previous study. Whole mRNA expression levels were acquired from microarray data for 60 identical gastric cancer patients. Two gastric adenocarcinoma subgroups with distinct mRNA expression profiles presented distinctly different prognoses. MicroRNA and protein expression patterns were compared between gastric cancer tissue and normal gastric tissue and between two different prognostic groups. Aberrantly expressed microRNA, associated mRNA, and protein in patients with poor-prognosis gastric cancer were validated by quantitative reverse transcription polymerase chain reaction and immunochemistry in independent patients. RESULTS: We obtained the expression data of 1146 microRNAs and 124 cancer-related proteins. Four microRNAs were aberrantly expressed in the two prognostic groups and in cancer vs non-cancer tissues (P < 0.05). In the poor-prognosis group, miR-196b, miR- 135b, and miR-93 were up-regulated and miR-29c* was down-regulated. miR-196b expression positively correlated with Homeobox A10 (HOXA10) expression (r = 0.726, P < 0.001), which was significantly increased in poor-prognosis patients (P < 0.001). Comparing gastric cancer with non-cancer tissues, 46/124 proteins showed differential expression (P < 0.05); COX2 (P < 0.001) and cyclin B1 (P = 0.017) were clearly overexpressed in the poor-prognosis group. CONCLUSION: Co-activation of miR-196b and HOXA10 characterized a poor-prognosis subgroup of patients with gastric cancer. Elucidation of the biologic function of miR-196b and HOXA10 is warranted.

AB - AIM: To identify molecular biologic differences between two gastric adenocarcinoma subgroups presenting different prognoses through the analysis of microRNA and protein expression. METHODS: Array technologies were used to generate 1146 microRNAs and 124 proteins expression profiles of samples from 60 patients with gastric cancer. For the integrative analysis, we used established mRNA expression data published in our previous study. Whole mRNA expression levels were acquired from microarray data for 60 identical gastric cancer patients. Two gastric adenocarcinoma subgroups with distinct mRNA expression profiles presented distinctly different prognoses. MicroRNA and protein expression patterns were compared between gastric cancer tissue and normal gastric tissue and between two different prognostic groups. Aberrantly expressed microRNA, associated mRNA, and protein in patients with poor-prognosis gastric cancer were validated by quantitative reverse transcription polymerase chain reaction and immunochemistry in independent patients. RESULTS: We obtained the expression data of 1146 microRNAs and 124 cancer-related proteins. Four microRNAs were aberrantly expressed in the two prognostic groups and in cancer vs non-cancer tissues (P < 0.05). In the poor-prognosis group, miR-196b, miR- 135b, and miR-93 were up-regulated and miR-29c* was down-regulated. miR-196b expression positively correlated with Homeobox A10 (HOXA10) expression (r = 0.726, P < 0.001), which was significantly increased in poor-prognosis patients (P < 0.001). Comparing gastric cancer with non-cancer tissues, 46/124 proteins showed differential expression (P < 0.05); COX2 (P < 0.001) and cyclin B1 (P = 0.017) were clearly overexpressed in the poor-prognosis group. CONCLUSION: Co-activation of miR-196b and HOXA10 characterized a poor-prognosis subgroup of patients with gastric cancer. Elucidation of the biologic function of miR-196b and HOXA10 is warranted.

UR - http://www.scopus.com/inward/record.url?scp=84887539112&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887539112&partnerID=8YFLogxK

U2 - 10.3748/wjg.v19.i41.7078

DO - 10.3748/wjg.v19.i41.7078

M3 - Article

C2 - 24222951

AN - SCOPUS:84887539112

VL - 19

SP - 7078

EP - 7088

JO - World Journal of Gastroenterology

JF - World Journal of Gastroenterology

SN - 1007-9327

IS - 41

ER -